SCHEMBL16301136

SCHEMBL16301136

CB(C)c1ccc(O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.55
CYP3A4 P08684 5/20 0.50
HSD17B10 Q99714 5/20 0.50
ALOX15 P16050 5/20 0.50
LMNA P02545 4/20 0.50
HIF1A Q16665 4/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
ALDH1A1 P00352 3/20 0.50
MAPT P10636 3/20 0.50
TYR P14679 2/20 0.50
HPGD P15428 2/20 0.50
CA3 P07451 2/20 0.50
CA14 Q9ULX7 2/20 0.50
KDM4E B2RXH2 1/20 0.50
NPC1 O15118 1/20 0.50
CA12 O43570 1/20 0.50
GMNN O75496 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12281931 0.83 CA2 (0.35) ENPP2CA1CA2
SCHEMBL12330470 0.79 ENPP2 (0.60) ENPP2CYP3A4HSD17B10ALOX15LMNA
SCHEMBL9945898 0.75 CA2 (0.60) ENPP2CA14KDM4ECA1CA2
SCHEMBL9946022 0.73 CA2 (0.39) CYP3A4ALDH1A1CA1CA2ESR1
SCHEMBL12282435 0.73 CA2 (0.39) CYP3A4ALDH1A1CA1CA2ESR1
Hydroquinone SCHEMBL7650500 0.73 CYP3A4 (0.57) ENPP2CYP3A4HSD17B10ALOX15LMNA
Hydroquinone SCHEMBL4309201 0.71 ALOX15 (0.80) CYP3A4HSD17B10ALOX15LMNAHIF1A
Hydroquinone SCHEMBL5200519 0.71 ALOX15 (0.80) CYP3A4HSD17B10ALOX15LMNAHIF1A
Hydroquinone SCHEMBL8087392 0.71 ALOX15 (0.80) CYP3A4HSD17B10ALOX15LMNAHIF1A
Hydroquinone SCHEMBL4071158 0.71 ALOX15 (0.80) CYP3A4HSD17B10ALOX15LMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108989-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-08-18 US disclosed
US-20140121183-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2014-05-01 US disclosed
US-8629125-B2 Inhibitors of fatty acid amide hydrolase Infinty Pharmaceuticals, Inc. (US) 2014-01-14 US disclosed
US-20130059819-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2013-03-07 US disclosed
US-8349814-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2013-01-08 US disclosed
US-20120076996-A1 RESIST COMPOSITION, RESIST FILM THEREFROM AND METHOD OF FORMING PATTERN THEREWITH FUJIFILM CORPORATION (JP) 2012-03-29 US disclosed
US-20110230440-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE ADAMS JULIAN 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140121183-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 ENPP2 36/4885CYP3A4 1007/4885HSD17B10 163/4885
US-20110230440-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 ENPP2 36/4885CYP3A4 1007/4885HSD17B10 163/4885
US-20130059819-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 ENPP2 36/4885CYP3A4 1007/4885HSD17B10 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.